COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma Announces Leadership Transition
15/10/2018
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (Naloxone HCI) Nasal Spray
15/10/2018
GAITHERSBURG, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of Adapt Pharma and its flagship product NARCAN ® (naloxone HCl) Nasal [...]
B. Braun Premieres Its New Wireless Syringe Pump at NANN 2018
15/10/2018
BETHLEHEM, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in infusion therapy and pain management, will premiere the wireless 2nd generation software for its Perfusor ® Space Syringe Pump, at the [...]
GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
15/10/2018
CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday, October 29, 2018. [...]
Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan
15/10/2018
WAYNE, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Pediapharm annonce la clôture de l’offre de reçus de souscription pour un produit brut total de 62 M$
15/10/2018
CE COMMUNIQUÉ NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS. NE PAS RESPECTER CETTE CONSIGNE PEUT CONSTITUER UNE VIOLATION DE LA LOI SUR LES TITRES DES ÉTATS-UNIS. MONTRÉAL, 15 [...]
Welldoc Announces Expansion of Program with Leading Academic Medical Center to Evaluate BlueStar® Digital Therapeutic as a Means of Transforming Population Health in Primary Care
15/10/2018
COLUMBIA, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Welldoc® today announced that one of the world’s leading academic medical centers is moving into Phase 2 for ongoing Quality Improvement research of BlueStar, its FDA- [...]
Sanofi: Disclosure of trading in own shares
15/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
15/10/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
15/10/2018
Announcement no. 61/2018 15 October 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Diffusion Pharmaceuticals Chief Financial Officer William “Bill” Hornung to Present at 2018 BIO Investor Forum
15/10/2018
Over 1,000 Attendees Expected; Opportunity to Learn About Company’s FDA Approval for Phase 2 On-Ambulance Stroke Trial and Phase 3 GMB Brain Cancer Trial Enrollment CHARLOTTESVILLE, Va., Oct. 15, 2018 (GLOBE NEWSWIRE [...]
Eurobio Scientific : MISE EN PLACE D'UN NOUVEAU CONTRAT DE LIQUIDITE AVEC LOUIS CAPITAL MARKETS
15/10/2018
MISE EN PLACE D'UN NOUVEAU CONTRAT DE LIQUIDITE AVEC LOUIS CAPITAL MARKETS Paris, le 15 octobre 2018 - 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical [...]
CO2 GRO is pleased to announce the Exercise of 6,214,035 Warrants for Proceeds of $1.24 Million
15/10/2018
TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ” or the “ Company ”) (TSX-V: GROW, OTCQB: BLONF) is pleased to announce that long term shareholders, holders of 6,214,035, $0.20 warrants [...]
Addus HomeCare Announces Third-Quarter 2018 Earnings Release and Conference Call
15/10/2018
Frisco, Texas, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2018 [...]
Biosenta Announces Signing Marketing Agreement for its high potency Disinfectant
15/10/2018
TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (Biosenta) announces that it has signed an agreement with F&M Merchant Group LLC (F&M) to launch its disinfectant, named “True,” in the U.S. market. Mr. [...]
CORRECTING and REPLACING – Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma
15/10/2018
Seven Cancer Centers in United States Open for Enrollment in Amended Trial NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Delcath Systems, Inc. (OTCQB: DCTH), [...]
Syneos Health Wins Society for Clinical Research Sites Eagle Award for Second Consecutive Year
15/10/2018
Investigative Sites Recognize Company’s Leadership in Advancing Clinical Research Through Collaborative Site Relationships RALEIGH, N.C., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully [...]
Jerome Workman Joins UBM Americas’ LCGC and Spectroscopy Editorial Team
15/10/2018
ISELIN, N.J., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Jerome Workman has joined UBM Americas as Senior Technical Editor of LCGC and Spectroscopy . Workman previously served as executive vice-president of Research & [...]
Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment Conference
15/10/2018
NORCROSS, Ga., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the [...]

Pages